Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine

doi:10.3748/wjg.v21.i15.4644

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7503)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

426

WORD

243

HTML

3240

Figures (1-2)

116

Tables (1-4)

Sum=4120

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

600

Download

1294

Sum=1894

Publishing Process of This Article

Item

Count

Browse

805

Download

684

Sum=1489

Apr 21, 2015 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Apr 21, 2015; 21(15): 4644-4651
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4644

Full Size Figure Download Figure

Figure 1 Change from baseline at week 48 in total hepatic hepatitis B virus DNA and hepatitis B virus covalently closed-circular DNA. ¹Adjusted for baseline total hepatic HBV DNA level; ²Adjusted for baseline hepatic cccDNA level. BL: Baseline; CI: Confidence interval; HGEq: Human genome equivalent; SE: Standard error; CccDNA: Covalently closed-circular DNA; ETV: Entecavir; LAM: Lamivudin.

Citation: Bowden S, Locarnini S, Chang TT, Chao YC, Han KH, Gish RG, de Man RA, Yu M, Llamoso C, Tang H. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine. World J Gastroenterol 2015; 21(15): 4644-4651
URL: https://www.wjgnet.com/1007-9327/full/v21/i15/4644.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i15.4644